4//SEC Filing
Kelly Jason R 4
Accession 0001127602-23-026331
CIK 0001830214other
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 4:53 PM ET
Size
7.3 KB
Accession
0001127602-23-026331
Insider Transaction Report
Form 4
Kelly Jason R
DirectorCEO & Founder
Transactions
- Sale
Class A Common Stock
2023-10-25$1.48/sh−100,000$147,600→ 5,794,680 total - Sale
Class A Common Stock
2023-10-26$1.46/sh−100,000$145,900→ 5,694,680 total
Footnotes (3)
- [F1]The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.41 to $1.535 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.43 to $1.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Documents
Issuer
Ginkgo Bioworks Holdings, Inc.
CIK 0001830214
Entity typeother
Related Parties
1- filerCIK 0001845677
Filing Metadata
- Form type
- 4
- Filed
- Oct 26, 8:00 PM ET
- Accepted
- Oct 27, 4:53 PM ET
- Size
- 7.3 KB